VSee Health (VSEE) entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 9,836,065 shares of common stock and warrants to purchase up to 19,672,130 shares of common stock at an effective combined price of $0.61 per share and common warrant for aggregate gross proceeds of approximately $6M, before deducting placement agent fees and other offering expenses. The warrants will have an exercise price of $0.61 per share, will be exercisable immediately following receipt of shareholder approval and will expire five years from the initial exercise date. The closing of the offering is expected to occur on or about December 1, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent in connection with the offering.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VSEE:
